首页> 外文期刊>Peritoneal dialysis international: Journal of the International Society for Peritoneal Dialysis >Intraperitoneal administration of drugs in peritoneal dialysis patients: a review of compatibility and guidance for clinical use.
【24h】

Intraperitoneal administration of drugs in peritoneal dialysis patients: a review of compatibility and guidance for clinical use.

机译:腹膜透析患者的腹​​膜内给药:对相容性和临床使用指南的综述。

获取原文
获取原文并翻译 | 示例
           

摘要

Peritoneal dialysis (PD) is an effective home-based therapy for end-stage renal failure. Intraperitoneal administration of drugs to PD patients is particularly important for the treatment of peritonitis. Clinicians need to know that the administered drug is compatible with both the PD solution and its container. A detailed literature search on drug compatibility and stability was performed and results of all published stability studies are presented for all drugs, PD solutions, and containers studied. These data will aid clinicians managing PD patients and provide a resource to demonstrate which drugs have been shown to be stable in various PD solutions and solution containers. This is important information to assist clinicians in applying effective treatments, in particular, for peritonitis.
机译:腹膜透析(PD)是终末期肾衰竭的有效家庭疗法。对PD患者腹膜内给药对治疗腹膜炎尤为重要。临床医生需要知道所用药物与PD溶液及其容器均兼容。进行了有关药物相容性和稳定性的详细文献搜索,并列出了所研究的所有药物,PD溶液和容器的所有已发表稳定性研究的结果。这些数据将帮助临床医生管理PD患者,并提供资源来证明在各种PD解决方案和溶液容器中已证明哪种药物稳定。这是重要的信息,有助于临床医生尤其是腹膜炎的临床治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号